|
innoget's
Monthly Newsletter
|
|
2 November
2011
|
|
Outstanding Technology Requests
|
|
|
|
Applicant Organization : Strategic Allies Ltd. / United Kingdom
Type of Technology Request : Licensing
Sector :
Electronics, Power
Tags :
wireless power, power Wi-Fi, contactless energy transfer
Desired outcome:
We are working with a European designer and manufacturer of electrical solutions for commercial, housing, healthcare, governmental and industrial applications. They are actively searching for innovative technology which enables the powering of everyday devices without the need to plug them in. Our client is interested in continuously powering every-day devices (such as PCs, TVs, etc.), simultaneously and within a room environment. Enabling technology will allow them to provide products that could replace electrical infrastructure (such as wiring, sockets, trunking, etc.) for offices, temporary meeting spaces and the home environment.
|
|
Applicant Organization : Whiteshield Partners / Canada
Type of Technology Request : Others
Sector :
Biotechnology, Chemical, Environment, Healthcare, Pharmaceutical
Tags :
Life Science Technology Request
Desired outcome:
I am seeking attractive investment opportunities among innovative life science companies. My organisation can offer grants, traditional financing and commercialization support to the right applicant. We can help SMEs enter emerging markets through participation in high-tech clusters.
|
|
Applicant Organization : anonymous company / United States
Type of Technology Request : Proof of concept
Sector :
Healthcare, Pharmaceutical
Tags :
device, pain relief, electrotherapy, portable
Desired outcome:
Seeking devices that can be used to relieve pain, particularly electrotherapy devices in the areas of microcurrent, low intensity ultrasound and pulsed shortwave therapy that have been developed to be portable and can be used by consumers rather than healthcare professionals. The device should also be capable of providing additional benefits such as promoting healing and can be used alone or with an additional active pharmaceutical ingredient (API) containing product.
|
|
Applicant Organization : anonymous company / United States
Type of Technology Request : Proof of concept
Sector :
Chemical, Healthcare, Pharmaceutical
Tags :
oral, dissolving film
Desired outcome:
Seeking orally dissolving thin film technologies with capabilities to load high amounts of active pharmaceutical ingredients (APIs) greater than 100mg. The oral thin film technology should also be able to provide taste masking capabilities or be able to include taste-masked API to ensure a palatable product is produced.
|
|
Applicant Organization : anonymous company / Spain
Type of Technology Request : Supplier
Sector :
Aerospace & defence, Biotechnology, Bulk products & materials, Chemical, Electronics, Healthcare, Water, Others
Tags :
fiber coating, photoreactive, shape memory, water resistant, heat resistant
Desired outcome:
We are looking for a Raw Material that can be mixed with other materials during a production process or for a finished product ready to be used as such. Ideally, a Raw Material supplier has a chemical compound of these properties to offer. If not, we will also be open to 1) get a license agreement, 2) acquire the product technology and/or 3) initiate a Joint Development.
|
|
Applicant Organization : anonymous company / Spain
Type of Technology Request : Proof of concept
Sector :
Food & drink
Tags :
salt substitution, salt reduction, Bread, baguette.
Desired outcome:
We want to produce bread and bakery products with the same sensory profile and 40% of salt reduction.
To produce wheat bread type baguette in industrial bakery at least 1/3 (33.3%) of salt reduction and preferably 40%. No changes in appereance, color, sensory scores and dough reology are required, related to standard product (without salt substitution).
|
|
Applicant Organization : TicSalut foundation / Spain
Type of Technology Request : Others
Sector :
Biotechnology, Chemical, Electronics, Healthcare
Tags :
Biomaterials, heart valve, prostheses, MISS application
Desired outcome:
SME with expertise and capabilities of performing biocompatibility tests (as stated in ISO 10993 and possibly including also subcutaneous rat tests), in order to be involved in a FP7 project in the field of NMP. Deadline 8th of Novembre 2011
|
|
Applicant Organization : ADVANCELL - Advanced in vitro cell technologies / Spain
Type of Technology Request : Licensing
Sector :
Biotechnology, Chemical, Healthcare, Pharmaceutical
Tags :
In-licensing, biotechnological products, small molecules, development to clinics, drug development
Desired outcome:
We in-license programs and develop them to Clinical Proof of Concept by using rigorous and results oriented development strategies.
We select projects according to different criteria with priority on:
- Repositioning of known molecules to new indications.
- Orphan Drugs for unmet clinical needs.
- New compounds with an evidence of safety/efficacy in relevant animal models
- New administration routes for already known molecules
Currently we are NOT interested in projects like:
- Diagnostic tools and medical devices.
- Drugs in late stages of clinical development (Phase II, Phase III).
- “New Chemical Entities” (NCE) without any safety evidence in animal models.
- Technology platforms without a defined lead.
Target areas: oncology, dermatology and neurology.
|
|
|
Outstanding Technology Offers
|
|
|
|
Vendor Organization : Zyrnat Biotherapeutics, S.L. / Spain
Type of Organization : Spin off, Start up
Current Development Status : Research or Experimental
Sector : Biotechnology, Healthcare, Pharmaceutical
Tags : Co-stimulation, solid organ transplantation, silencing-RNA, autoimmune disease, organ rejection
Description of the technology offer
Co-stimulatory silencing-RNA oligonucleotides are powerful deactivators of the innate and adaptive immune response. As such, they offer the opportunity of preventing immune-mediated injury and rejection in allo-geneic organ transplantation as well as preventing organ damage in inflammatory autoimmune diseases.
|
|
Vendor Organization : Laser Consult Ltd. / Hungary
Type of Organization : Research group (university, research center)
Current Development Status : Proof of Concept or Laboratory Prototype
Sector : Biotechnology, Healthcare, Pharmaceutical
Tags : bionanocomposite, pharmaceutical, core-shell structure, cytokine, bioactive protein core
Description of the technology offer
Our partner, a Hungarian University has developed a novel invention which relates to a sustained release, core-shell structure, cytokine-containing bionanocomposite, a process for preparation thereof and use of said core-shell bionanocomposite in the preparation of a sustained release pharmaceutical composition.
|
|
Vendor Organization : Laser Consult Ltd. / Hungary
Type of Organization : Research group (university, research center)
Current Development Status : Research or Experimental
Sector : Biotechnology, Healthcare, Pharmaceutical
Tags : kynurenic acid, Huntington’s disease, NMDA, Excitotoxicity
Description of the technology offer
Our partner, a Hungarian University has developed a novel invention which is directed to kynurenic acid amide analogues for use for curing the symptoms of Huntington’s disease as well as for preventing the development of said symptoms. The client is interested in finding partners for preclinical trial.
|
|
Vendor Organization : anonymous company / India
Type of Organization : Others (scientists, inventors, …)
Current Development Status : Proof of Concept or Laboratory Prototype
Sector : Healthcare, Pharmaceutical
Tags : Coprocessed Excipients
Description of the technology offer
Dose dumping is most commonly seen in drugs taken by mouth and digested in the gastrointestinal tract. Around the same time patients take their medication, they can also ingest other substances like fatty meals or alcohol that increase drug delivery. The substances may act on the drug's dosage form to speed up drug release, or they may stimulate the body's absorptive surfaces to increase the rate of drug uptake.
We have developed the co-processed ready mix coating excipient system which can avoid the dose dumping and minimize the adverse toxic effects.
|
|
Vendor Organization : anonymous company / United States
Type of Organization : Others (scientists, inventors, …)
Current Development Status : Research or Experimental
Sector : Aerospace & defence, Transport
Tags : engine, motor, electric, zero-emission, vehicle, Automotive, rail, railway, marine, aerospace
Description of the technology offer
The electric motor is powerful enough to move an object weighing 3175 Kilograms (or 7000 lbs) from 0 meters per second (0 miles per hour) to 26 meters per second (60 miles per hour) in under 11 seconds but small enough to be placed in the motor compartment of any contemporary vehicle and use only 1200 watts of power.
|
|
Vendor Organization : DELPHI GENETICS / Belgium
Type of Organization : Small and medium size company (SME)
Current Development Status : Commercially Available
Sector : Biotechnology, Healthcare, Pharmaceutical
Tags : recombinant protein, ADN, ANTIBIOTIC FREE, E COLI, ESCHERICHIA COLI, vaccine, fermentation
Description of the technology offer
Technology to improve protein and DNA production by plasmid stabilization. This technology allows to work without antibiotics marker.
The technology not only allows to remove the antibiotics it also increase significantly the yield of production. For some proteins that are more difficult to express this technology has been shown to be an enabling technology.
|
|
Vendor Organization : New wave Medical / United States
Type of Organization : Others (scientists, inventors, …)
Current Development Status : Proof of Concept or Laboratory Prototype
Sector : Healthcare, Pharmaceutical
Tags : Syringe, pre-filled, pharmaceutical, biologicals, Health Care, medical device, Drug delivery
Description of the technology offer
The principal benefits of this system are:
1) lower cost for manufacturers, providers and end-users,
2) improved storage, shipping and logistics,
3) extended shelf life of pharmaceutical products
4) improved safety, regulatory compliance and lower medical waste.
Also, while doing all the above, it should not lose flexibility of the present syringe working in both directions (injection and extraction). This is the truly Green Technology in Healthcare.
New Wave Medical, L.L.C. (NWM) is a parenteral drug technology company applying manufacturing innovation to enhance the therapeutic value and market availability of parenterally delivered pharmaceuticals and vaccines. Our company was founded by Mr. Boris Zubry after he invented Magnetic Plungerless Injection System (MPIS) (patent # 7,255,684).
|
|
Vendor Organization : anonymous company / Kazakhstan
Type of Organization : Others (scientists, inventors, …)
Current Development Status : Research or Experimental
Sector : Aerospace & defence, Bulk products & materials, Transport
Tags : Transport machinery, the most miscellaneous equipment, Torque, Mechanical Homeostat, transport machines
Description of the technology offer
I have developed a kinematic configuration and “The Theory of Mechanical Transformer of a Torque”.
Almost all industries require reliable mechanisms with stepless change of transfer functions.The idea of such mechanism exists for a long time. In the engineering literature it is commonly called Transformer of Torque (TT). TT allows implementing the basic principle of dynamics: “Winning in force, losing in speed; winning in speed, losing in force”, and it is considered as cybernetic system. In the long term it is a mechanical HOMEOSTAT, the device exercising control in conditions of initial uncertainty, on the basis of the current information on the varying parameter.
|
|
Vendor Organization : chungang univ. / Korea, Republic of
Type of Organization : Research group (university, research center)
Current Development Status : In Use Testing Results Available
Sector : Electronics
Tags : CCTV, auto focus, smart image analysis device
Description of the technology offer
○ Smart video analysis device technology to detect moving object on the video captured by rotational camera and track clear image using automatic focusing function
○ Iris device to automatically get focus by measuring distance information of the subject
○ To overcome restriction on visual field of camera over the whole range using PTZ (Pan Tilt Zoom) camera with turning movement (revolution) - Even though the moving object goes out of vision, it can be constantly present within the visual field by moving the rotation motor.
○ To fast recover deteriorated image with automatic focus recovery on the basis of movement of color channel and prevent image quality from deteriorating, reblurring or ringing phenomenon
|
|
Vendor Organization : KOREA ELECTRONICS TECHNOLOGY INSTITUTE / Korea, Republic of
Type of Organization : Research group (university, research center)
Current Development Status : In Use Testing Results Available
Sector : Electronics
Tags : TOUCH SCREEN PANEL, SMART PHONE, TSP, 3D
Description of the technology offer
○ Capacitance type of Tactitle Touch Screen technology in capacitance using transparent CNT electrode
○ Possible to express sensitivity of users and various User Interfaces
○ Capacitance type of Tactitle Touch Screen Panel using transparent CNT electrode
○ Possible to recognize size with touch weight (force) beyond over simple On/Off touch driving
|
|
Vendor Organization : Pusan National University / Korea, Republic of
Type of Organization : Research group (university, research center)
Current Development Status : Commercially Available
Sector : Communications, Software, Transport
Tags : RFID, Tracking Object
Description of the technology offer
Innovative, Efficiency
- The existing method requires installation cost of multiple RFIDs by dividing space and placing sensors to include all area of RFID for positioning. However, this RFID tracing method allows efficient indoor positioning with low cost.
- Efficient allocation of RFIDs utilizing accessibility graph
- Graph to determine 3 dimensional phase
|
|
Vendor Organization : Soongsil University / Korea, Republic of
Type of Organization : Research group (university, research center)
Current Development Status : Working Prototype or Samples Ready for Testing
Sector : Communications, Electronics
Tags : Smart phone charging, electric car charging
Description of the technology offer
▴Wireless Energy Transmission/Charging Technology to allow charging the secondary electricity mounted on portable electronic devices (mobile phone, tablet PC, etc.) home appliances, electric car, etc.
▴As this technology magnetic field charging technology of magnetic resonance method applied with meta material, it has excellent electric power transmission efficiency comparing device size and transmission distance with the existing magnetic induction method.
|
|
Vendor Organization : Albert Six
Type of Organization : Others (scientists, inventors, …)
Current Development Status : Proof of Concept or Laboratory Prototype
Sector : Aerospace & defence, Power, Transport, Others
Tags : gearbox, speed variators, CVT, Continuously Variable Transmission, torque converter, drive train
Description of the technology offer
This mechanical device is a NEW way to combine a differential and a speed variator. There are no electrical components.The input torque is divided into two channels. It is the way we recombine those two channels that controls the output. The Torque Box transforms the power of the motor (or turbine, gas engine...) into any speed or torque needed by the user. When more power is needed, the torque of the input can be increased without changing its speed. The motor is kept running at its optimum speed and saves energy.The output speed can vary CONTINUOUSLY from zero to the maximum speed. No need to switch gears in cars or trucks.
In many industries the size of the motor is determined by the maximum torque necessary. When the output speed of the Torque box goes down to zero the output torque can increase indefinitely. Many motors can be downsized.
|
|
Vendor Organization : Oryzon Genomics / Spain
Type of Organization : Spin off, Start up
Current Development Status : Commercially Available
Sector : Biotechnology, Healthcare, Pharmaceutical
Tags : biomarket, target, Diagnosis, drug discovery
Description of the technology offer
We can offer an intergrated technological platform including:
Genomics: including gene expression, copy number variation, and differential splicing analysis.
Bioinformatics: including mode of action studies.
Development of accompanying markers for in vivo efficacy studies.
Target validation: RNAi and in vitro assays
Development of new biochemical or cellular assays including cell panel testing.
B2D2 Platform: including fragment-screening, crystallography and molecular modeling.
|
|
Vendor Organization : Environmental and Industrial Applications of Catalysis / Spain
Type of Organization : Spin off, Start up
Current Development Status : In Use Testing Results Available
Sector : Chemical, Environment, Water
Tags : nitrates, Water, drinking water, catalysis, nitrites, potable water, catalytic hydrogenation
Description of the technology offer
Innovative technology developed at the University of Tarragona (Spain) capable to remove nitrates and nitrites from water, getting drinking water (desired values of nitrates < 50 ppm). The nitrates removal consists in a catalytic reaction that converts nitrates and nitrites into Nitrogen gas in one step using hydrogen gas as reactant. The reaction occurs in a catalytic reactor provided by APLICAT that works in a continuous mode. The products are nitrogen gas and clean water
|
|
Vendor Organization : University of Salamanca / Spain
Type of Organization : Technology transfer organization (TTO)
Current Development Status : In Use Testing Results Available
Sector : Biotechnology, Chemical, Healthcare, Pharmaceutical
Tags : pharmaceutics, care, Hygiene, beauty, drugs, pharmaceutical products, health services
Description of the technology offer
Researchers from the department of Chemical Engineering of the University of Salamanca have developed a new system to produce microcapsules with an air-blast atomizer. It is a soft method that does not involve one of two harsh conditions usually used, neither contact with an organic solvent nor heating during processing. Both the system and method, via ionic gelation, use only biocompatible materials with no added chemicals other than sodium alginate and barium chloride. The capsules generated with an air-blast atomizer, in contrast with previous work done without harsh conditions, have a minor size: ranged between 10-50 microns.
|
|
Vendor Organization : University of Salamanca / Spain
Type of Organization : Technology transfer organization (TTO)
Current Development Status : In Use Testing Results Available
Sector : Healthcare, Pharmaceutical, Others
Tags : pharmaceutics, care, Hygiene, beauty, care and health services, drugs, medical textiles
Description of the technology offer
Researchers from the department of Chemical Engineering of the University of Salamanca in collaboration with health personnel from the Universitary Hospital have designed and developed a new kind of drug delivery matrixes to vascularize, cicatrize and regenerate tissues and/or organs.
The invention is useful to vascularize and cicatrize tissues and/or organs of some important diseases but also in industrial applications, i.e., intelligent textiles, cosmetics, etc.
The matrix comprises two faces of equal or different structure: one for its adherence to the organ or tissue, and the other one for a protection of the area. Moreover these kinds of matrixes comprise growth factors that prevent the degradation and optimize the vascularisation. The matrix allows the sequential release of one or more different molecules simultaneously.
|
|
|
|
|
|
Advertisers
|
|
|
|
|
|
|
|
Interesting News
|
|
|
|
|
|
|
|
|
|
2011-07-28 Axiom Groupe: 4th edition of the pan-European business meeting on Innovation Excellence (Barcelona 24-25th of November)
During these two days Vice Presidents and Heads of Innovation, Research & Development, Strategic Renewal, Technology, of Alstom, Unilever, Alcatel-Lucent, Bankinter, Deutsche Telekom, Alfa Laval, Clariant, Valeo, Fujitsu, Dow, Sitra, et... read more
|
|
|
|
|
Your e-mail address as well as your personal details are kept at Innoget's files so that we can establish a professional or commercial relationship as well as keep you informed about our services. You will have the right to have access to your personal details as well as modify or cancel them writing an e-mail to info@innoget.com or by post to the following address: Av. Ernest Lluch, 32 - TCM2, 08302, Mataró (Barcelona) Spain
© 2011 Innoget
|
|
|
